USANA Health Sciences, Inc. (NYSE:USNA) insider Kevin Guest sold 29,934 shares of the business’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $59.01, for a total transaction of $1,766,405.34. Following the completion of the sale, the insider now directly owns 10,549 shares of the company’s stock, valued at $622,496.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of USANA Health Sciences, Inc. (NYSE USNA) opened at 59.45 on Friday. The company has a 50-day moving average of $59.52 and a 200-day moving average of $60.19. USANA Health Sciences, Inc. has a 12 month low of $52.55 and a 12 month high of $75.00. The stock has a market capitalization of $1.45 billion, a PE ratio of 15.44 and a beta of 1.10.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, July 25th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.06 by $0.08. The business had revenue of $257.10 million during the quarter, compared to the consensus estimate of $273.61 million. USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. The company’s quarterly revenue was down .5% compared to the same quarter last year. During the same period last year, the firm earned $2.07 EPS. On average, equities research analysts expect that USANA Health Sciences, Inc. will post $3.79 EPS for the current fiscal year.

USANA Health Sciences announced that its Board of Directors has initiated a stock buyback plan on Tuesday, July 25th that allows the company to repurchase $64.60 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 46% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

COPYRIGHT VIOLATION WARNING: “USANA Health Sciences, Inc. (USNA) Insider Sells $1,766,405.34 in Stock” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another publication, it was stolen and republished in violation of international copyright legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/08/26/usana-health-sciences-inc-usna-insider-sells-1766405-34-in-stock.html.

A number of equities research analysts recently weighed in on USNA shares. Pivotal Research reissued a “hold” rating and issued a $55.00 price target (down from $75.00) on shares of USANA Health Sciences in a research report on Monday, May 1st. BidaskClub cut shares of USANA Health Sciences from a “buy” rating to a “hold” rating in a research report on Tuesday, June 20th.

A number of large investors have recently made changes to their positions in USNA. BNP Paribas Arbitrage SA raised its stake in shares of USANA Health Sciences by 13.1% in the second quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock valued at $135,000 after buying an additional 245 shares during the period. Victory Capital Management Inc. raised its stake in shares of USANA Health Sciences by 124.7% in the first quarter. Victory Capital Management Inc. now owns 2,117 shares of the company’s stock valued at $122,000 after buying an additional 1,175 shares during the period. Creative Planning raised its stake in shares of USANA Health Sciences by 528.0% in the second quarter. Creative Planning now owns 2,512 shares of the company’s stock valued at $161,000 after buying an additional 2,112 shares during the period. SG Americas Securities LLC acquired a new stake in shares of USANA Health Sciences during the second quarter valued at about $162,000. Finally, Eqis Capital Management Inc. acquired a new stake in shares of USANA Health Sciences during the second quarter valued at about $210,000. 43.57% of the stock is currently owned by hedge funds and other institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Stock Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related stocks with our FREE daily email newsletter.